According to leaked internal documents, black people were injected with ASBESTOS!
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
The deranged Big Pharma experiment involved injecting a group of majority-black Pennsylvanians with highly-toxic asbestos to determine whether the substance was safe to use in talcum powder.
This raises some serious moral questions, especially regarding the fact that the BLM movement was popular and supported by the same government at the very same time.
“Documents confirming the company’s involvement were obtained by Bloomberg, tying the New Jersey-based Big Pharma and vaccine company to human experiments led by Dr Albert Kligman, a University of Pennsylvania dermatologist whose experiments on American citizens have widely condemned as brutal and unethical.”
“nmates at Holmesburg Prison in Philadelphia, Pennsylvania, were offered $10 to $300 – equivalent to between $100 to $2,500 in today’s money when adjusted for inflation – to take part in the study – though they were likely unaware of the significant risk they were undertaking.
Participants were injected with asbestos and talc – a powder that forms the base of J&J’s iconic baby powder product. Asbestos is an extremely dangerous chemical that is tied to lung cancers, among other conditions.
Researchers hoped to determine whether asbestos could safety be used in talc-based powder without causing negative reactions from subjects.
Many participants were gravely harmed, though. One was Leodus Jones, whose daughter described his injuries has so jarring that he had turned into a ‘monster’. Jones died in 2018 aged 74, having suffered a lifetime of horrific pain as a result of the experiments.
Dow Chemical, a Michigan based chemical manufacturing company, and the U.S. government have been previously tied to these experiments as well.”
The University of Pennsylvania has distanced itself from Kligman, and in 2021 issued and official apology for his actions.
‘Penn Medicine apologizes for the pain Dr Kligman’s work caused to incarcerated individuals, their families, and our broader community, Dr J Larry Jameson, executive vice president of the school, wrote in a letter.
‘While we cannot alter this history, the actions we are announcing today as an institution will change significant aspects of how we recognize Dr Kligman and his research, and will also devote substantial resources to research focused on skin of color and to education and patient care for underserved and vulnerable populations.’